Stephen James Luen, Pawan Bajaj, Prunella Blinman, Jayesh Desai, Sophia Frentzas, Hui Kong Gan, Ortis Estacio, Samuel John Harris, Ben Markman, Michael Millward, Catherine M. Shannon, Hilmar Ebersbach, Claudia Berger, Christoph Renner. "Re-sensitizing PD-1/PD-L1 relapsed/refractory solid tumors: Phase 1a results of IOS-1002, a LILRB1/2 and KIR3DL1 checkpoint inhibitor, in combination with pembrolizumab.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.2501